Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis
Clinical trial NCT02214888 · TERMINATED
Trial details
- NCT number
- NCT02214888
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2004-01-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.